(A) Normal human endometrium specimens from subjects in proliferative and secretory phases were immunoblotted using EMP2 antisera

Abstract

β-actin was used as a loading control. (B) Statistical analysis of EMP2 expression levels in proliferative (n = 3: subphase unspecified) and secretory (n = 3: one post-ovulatory day 3, one late, one unspecified) endometrial specimens from six independent patients. Data were analyzed using a 2-tailed, unpaired student t-test with a 95% confidence interval. *Changes in expression between the proliferative and secretory endometrium were significant, p = 0.038.<p><b>Copyright information:</b></p><p>Taken from "Steroid hormone regulation of EMP2 expression and localization in the endometrium"</p><p>http://www.rbej.com/content/6/1/15</p><p>Reproductive biology and endocrinology : RB&E 2008;6():15-15.</p><p>Published online 9 Apr 2008</p><p>PMCID:PMC2329639.</p><p></p

    Similar works

    Full text

    thumbnail-image

    Available Versions